跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AIMOVIG erenumab 140 mg/mL solution for injection in pre-filled pen - TGA Drug Approval Details
Approvals
/
TGA
/
AIMOVIG erenumab 140 mg/mL solution for injection in pre-filled pen
Approved
STANDARD
AIMOVIG erenumab 140 mg/mL solution for injection in pre-filled pen
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
42d6230962235eb0
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
42d6230962235eb0
Product Name
AIMOVIG erenumab 140 mg/mL solution for injection in pre-filled pen
Artg Id
309205
Artg Name
AIMOVIG erenumab 140 mg/mL solution for injection in pre-filled pen
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2019-10-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/80ee4d1a26d427f2fc2f6a632b469fc9.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
42d6230962235eb0
Type
Standard
Back to TGA Approvals